Dr. Professor John Gribben

• Professor John Gribben graduated from the University of Glasgow in 1980.
• He trained in Haematology at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School.
  
• He remained on the faculty at Harvard Medical School for 17 years before returning to the UK.
• He specialises in haematological cancers including lymphomas, leukaemias, and bone marrow transplantation.
• His NHS post is as Consultant Haematologist and Medical Oncologist at Barts and The London NHS Trust.
• He has authored more than 300 articles and chapters in peer-reviewed publications.
• He has an international reputation for pioneering research into new drugs and forms of cancer treatment.
• His studies in leukaemia and lymphoma have been supported by grant funding from The National Cancer Institute and Cancer Research UK.
• He has chaired and served on numerous international executive committees dedicated to improving cancer care.
• He is a member of the editorial boards of several professional publications focused on cancer.
• He has delivered lectures worldwide on new therapies for cancer treatment.

Conditions treated by Dr. Professor John Gribben

• Lymphomas (including Hodgkin’s and Non-Hodgkin’s lymphoma)
• Leukaemias (acute and chronic forms, including CLL and AML)
• Myeloma (multiple myeloma and related plasma cell disorders)
• Bone marrow failure syndromes
• Blood cancers requiring bone marrow transplantation
• Complications of chemotherapy and targeted therapies
• Relapsed and refractory haematological cancers

Area of Interest

• Haematology and Oncology